Aliskiren/amlodipine

The drug combination aliskiren/amlodipine (INNs, trade names Tekamlo and Rasilamlo) is an antihypertensive. Clinical trials have shown it to be more effective than amlodipine on its own,^[1] with a high dosing regime (aliskiren 300 mg/amlodipine 10 mg) being more effective than olmesartan/amlodipine with comparable tolerability.^[2]

Aliskiren/amlodipine

Combination of
Aliskiren	Renin inhibitor
Amlodipine	Calcium channel blocker (dihydropyridine)
Clinical data
Trade names	Tekamlo, Rasilamlo
AHFS/Drugs.com	Professional Drug Facts
License data	US FDA: Tekamlo
Pregnancy category	C in first trimester; D in second and third trimesters
Routes of administration	By mouth
ATC code	C09XA53 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
CAS Number	1416233-20-9 N
NY (what is this?)  (verify)